Allergan

Page 6 of 6

Is Valeant the wrong partner for Bill Ackman’s bid for Allergan?

Is Valeant the wrong partner for Bill Ackman’s bid for Allergan?

By
October 30, 2014
Botox
Finance

SEC is reportedly probing the Valeant-Ackman bid for Botox-maker Allergan

By
August 14, 2014
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Bill Ackman confirms Pershing Square Holdings IPO plan

By
August 13, 2014
Invest Todd Ahlsten
Finance

Riding high, with one eye on the ‘What If?’

By
July 7, 2014
Morgan Stanley caught playing both sides of Allergan-Valeant fight
Finance

Morgan Stanley caught playing both sides of Allergan-Valeant fight

By
June 16, 2014
Botox Treatment
Finance

Allergan and Valeant are both hypocrites

By
June 2, 2014
Valeant Offers to Buy Allergan With Pershing's Support
Finance

Valeant injects more cash into bid for Botox-maker Allergan

By
May 30, 2014
Fortune
Finance

Valeant boosts bid to buy Botox-maker Allergan

By
May 28, 2014
Fortune

Valeant ready to beef up bid for maker of Botox

By
May 13, 2014
Fortune
Finance

Allergan rejects Valeant’s $46 billion takeover bid

By
May 12, 2014

Most Popular